

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the understanding and management... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1362/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1362" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the understanding and management of oropharyngeal cancer" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the understanding and management of oropharyngeal cancer.">
            <meta name="og:description" content="Read the latest article version by Ashley Hay, Iain J. Nixon, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15692">
            <meta name="article-id" content="14416">
            <meta name="dc.title" content="Recent advances in the understanding and management of oropharyngeal cancer">
            <meta name="dc.description" content="Oropharyngeal squamous cell carcinoma (OPSCC) is an increasing health problem in the developing and developed world. In recent years, there have been major changes in the treatment paradigms for OPSCC. This is because of a number of reasons: the understanding and discovery of a new viral etiology (the human papillomavirus [HPV]), changes in practice patterns owing to advances in radiotherapy, and then an organ preservation strategy with the increased use of chemotherapy. Next came the development of new surgical technologies and the emergence of a new treatment modality, immunotherapy. In this article, we discuss the evolution of OPSCC treatments, starting with the traditional tobacco era. Treatment paradigms then evolved during the organ preservation era, the HPV era, and the minimally invasive surgery era. We are currently in the immunotherapy era, with a number of new drugs becoming available both on trial and by approval for use in the clinical setting for head and neck cancer patients. We discuss a number of trials and the reasons behind attempts at both treatment escalation and treatment de-escalation.">
            <meta name="dc.subject" content="Oropharynx, Squamous cell carcinoma, Robotics, Immunotherapy, IMRT">
            <meta name="dc.creator" content="Hay, Ashley">
            <meta name="dc.creator" content="Nixon, Iain J.">
            <meta name="dc.date" content="2018/08/30">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14416.1">
            <meta name="dc.source" content="F1000Research 2018 7:1362">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Oropharynx">
            <meta name="prism.keyword" content="Squamous cell carcinoma">
            <meta name="prism.keyword" content="Robotics">
            <meta name="prism.keyword" content="Immunotherapy">
            <meta name="prism.keyword" content="IMRT">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/08/30">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1362">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14416.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1362">
            <meta name="citation_title" content="Recent advances in the understanding and management of oropharyngeal cancer">
            <meta name="citation_abstract" content="Oropharyngeal squamous cell carcinoma (OPSCC) is an increasing health problem in the developing and developed world. In recent years, there have been major changes in the treatment paradigms for OPSCC. This is because of a number of reasons: the understanding and discovery of a new viral etiology (the human papillomavirus [HPV]), changes in practice patterns owing to advances in radiotherapy, and then an organ preservation strategy with the increased use of chemotherapy. Next came the development of new surgical technologies and the emergence of a new treatment modality, immunotherapy. In this article, we discuss the evolution of OPSCC treatments, starting with the traditional tobacco era. Treatment paradigms then evolved during the organ preservation era, the HPV era, and the minimally invasive surgery era. We are currently in the immunotherapy era, with a number of new drugs becoming available both on trial and by approval for use in the clinical setting for head and neck cancer patients. We discuss a number of trials and the reasons behind attempts at both treatment escalation and treatment de-escalation.">
            <meta name="citation_description" content="Oropharyngeal squamous cell carcinoma (OPSCC) is an increasing health problem in the developing and developed world. In recent years, there have been major changes in the treatment paradigms for OPSCC. This is because of a number of reasons: the understanding and discovery of a new viral etiology (the human papillomavirus [HPV]), changes in practice patterns owing to advances in radiotherapy, and then an organ preservation strategy with the increased use of chemotherapy. Next came the development of new surgical technologies and the emergence of a new treatment modality, immunotherapy. In this article, we discuss the evolution of OPSCC treatments, starting with the traditional tobacco era. Treatment paradigms then evolved during the organ preservation era, the HPV era, and the minimally invasive surgery era. We are currently in the immunotherapy era, with a number of new drugs becoming available both on trial and by approval for use in the clinical setting for head and neck cancer patients. We discuss a number of trials and the reasons behind attempts at both treatment escalation and treatment de-escalation.">
            <meta name="citation_keywords" content="Oropharynx, Squamous cell carcinoma, Robotics, Immunotherapy, IMRT">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Ashley Hay">
            <meta name="citation_author_institution" content="Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, USA">
            <meta name="citation_author" content="Iain J. Nixon">
            <meta name="citation_author_institution" content="Department of Otolaryngology Head and Neck Surgery, NHS Lothian, Edinburgh, UK">
            <meta name="citation_publication_date" content="2018/08/30">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1362">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14416.1">
            <meta name="citation_firstpage" content="1362">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1362/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1362.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15692 /> <input type=hidden id=articleId name=articleId value=14416 /> <input type=hidden id=xmlUrl value="/articles/7-1362/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1362-v1.xml"> <input type=hidden id=article_uuid value=ffd58d39-9c02-490b-bde7-fa157920a73d /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in the understanding and management of oropharyngeal cancer"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14416.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14416.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1362"
  },
  "headline": "Recent advances in the understanding and management of oropharyngeal cancer",
  "datePublished": "2018-08-30T15:14:47",
  "dateModified": "2018-08-30T15:14:47",
  "author": [
    {
      "@type": "Person",
      "name": "Ashley Hay"
    },    {
      "@type": "Person",
      "name": "Iain J. Nixon"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Oropharyngeal squamous cell carcinoma (OPSCC) is an increasing health problem in the developing and developed world. In recent years, there have been major changes in the treatment paradigms for OPSCC. This is because of a number of reasons: the understanding and discovery of a new viral etiology (the human papillomavirus [HPV]), changes in practice patterns owing to advances in radiotherapy, and then an organ preservation strategy with the increased use of chemotherapy. Next came the development of new surgical technologies and the emergence of a new treatment modality, immunotherapy. In this article, we discuss the evolution of OPSCC treatments, starting with the traditional tobacco era. Treatment paradigms then evolved during the organ preservation era, the HPV era, and the minimally invasive surgery era. We are currently in the immunotherapy era, with a number of new drugs becoming available both on trial and by approval for use in the clinical setting for head and neck cancer patients. We discuss a number of trials and the reasons behind attempts at both treatment escalation and treatment de-escalation."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1362.html",
            "name": "Recent advances in the understanding and management of oropharyngeal..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the understanding and management of oropharyngeal... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15692 data-id=14416 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14416.1" data-recommended="" data-doi="10.12688/f1000research.14416.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1362/v1/pdf?article_uuid=ffd58d39-9c02-490b-bde7-fa157920a73d" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14416-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14416-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14416-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Hay A and Nixon IJ. Recent advances in the understanding and management of oropharyngeal cancer [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1362 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14416.1" target=_blank>https://doi.org/10.12688/f1000research.14416.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14416-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14416 id=track-article-signin-14416 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14416?target=/articles/7-1362.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15692 /> <input name=articleId type=hidden value=14416 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the understanding and management of oropharyngeal cancer</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:ash.hay@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Ashley Hay</span></a><a href="https://orcid.org/0000-0002-4666-836X" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-4666-836X</div><sup>1</sup>,&nbsp;</span><span class="">Iain J. Nixon<sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:ash.hay@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Ashley Hay</span></a><a href="http://orcid.org/0000-0002-4666-836X" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-4666-836X</div><sup>1</sup>,&nbsp;</span><span class="">Iain J. Nixon<sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 30 Aug 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14416.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, USA<br/> <sup>2</sup> Department of Otolaryngology Head and Neck Surgery, NHS Lothian, Edinburgh, UK<br/> <p> <div class=margin-bottom> Ashley Hay <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Iain J. Nixon <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=38219-37726></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=38220-37459></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=38221-37727></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Oropharyngeal squamous cell carcinoma (OPSCC) is an increasing health problem in the developing and developed world. In recent years, there have been major changes in the treatment paradigms for OPSCC. This is because of a number of reasons: the understanding and discovery of a new viral etiology (the human papillomavirus [HPV]), changes in practice patterns owing to advances in radiotherapy, and then an organ preservation strategy with the increased use of chemotherapy. Next came the development of new surgical technologies and the emergence of a new treatment modality, immunotherapy. In this article, we discuss the evolution of OPSCC treatments, starting with the traditional tobacco era. Treatment paradigms then evolved during the organ preservation era, the HPV era, and the minimally invasive surgery era. We are currently in the immunotherapy era, with a number of new drugs becoming available both on trial and by approval for use in the clinical setting for head and neck cancer patients. We discuss a number of trials and the reasons behind attempts at both treatment escalation and treatment de-escalation. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Oropharynx, Squamous cell carcinoma, Robotics, Immunotherapy, IMRT </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Ashley Hay (<a href="mailto:ash.hay@gmail.com">ash.hay@gmail.com</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Ashley Hay </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Hay A and Nixon IJ. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Hay A and Nixon IJ. Recent advances in the understanding and management of oropharyngeal cancer [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1362 (<a href="https://doi.org/10.12688/f1000research.14416.1" target=_blank>https://doi.org/10.12688/f1000research.14416.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 30 Aug 2018, <b>7</b>(F1000 Faculty Rev):1362 (<a href="https://doi.org/10.12688/f1000research.14416.1" target=_blank>https://doi.org/10.12688/f1000research.14416.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 30 Aug 2018, <b>7</b>(F1000 Faculty Rev):1362 (<a href="https://doi.org/10.12688/f1000research.14416.1" target=_blank>https://doi.org/10.12688/f1000research.14416.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d12324e140>Introduction</h2><div class=section><a name=d12324e143 class=n-a></a><h3 class=section-title>Anatomy and histology of the oropharynx</h3><p class="" id=d12324e148>Oropharyngeal squamous cell carcinoma (OPSCC) refers to squamous cancers that develop in the posterior third of the tongue, tonsils, soft palate, and posterior pharyngeal wall<sup><a href="#ref-1">1</a></sup>. Within these subsites of the oropharynx, the tonsil and tongue base are the most common sites to be affected by carcinoma. These sites differ from the other subsites because they have a high density of lymphoid cells and show a strong association with human papillomavirus (HPV)-related squamous carcinoma. The strong predilection of HPV for the oropharynx is due to the microanatomy of the reticulated epithelium (epithelium with an immune system component) of the base of the tongue and tonsils<sup><a href="#ref-2">2</a></sup>. HPV infects the reticulated epithelium lining the deep tonsillar crypts. The deep crypts of tonsils are immune-privileged sites, which means they can tolerate the introduction of antigens without eliciting an inflammatory immune response. This results in inhibition of the effector function of the HPV-specific T cells and thereby facilitates immune evasion at the time of initial HPV infection<sup><a href="#ref-3">3</a></sup>.</p><p class="" id=d12324e163>In this article, we will discuss the evolution in understanding of OPSCC and describe how this has impacted on treatment options and research opportunities in this field.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12324e170>The evolution of oropharyngeal squamous cell carcinoma</h2><div class=section><a name=d12324e173 class=n-a></a><h3 class=section-title>Tobacco era</h3><p class="" id=d12324e178>Traditionally, oropharyngeal carcinoma was closely related to tobacco and alcohol exposure. The incidence of carcinoma in the oropharynx was similar to that in the other sites of the upper aero-digestive tract that all shared common exposure to the carcinogens in tobacco<sup><a href="#ref-4">4</a></sup>. There was also a high incidence of comorbidity in these patients from associated tobacco exposure conditions. Treatment was typically with surgery, as most tumors were locally advanced at presentation. Open approaches, such as mandibulotomy, were used to access the oropharynx. Long-term support of airway and feeding was often required in the form of a gastrostomy feeding tube and a tracheostomy. Radiotherapy was used post-operatively to optimize loco-regional control. With developments in the delivery of radiation and the recognition that primary non-surgical management was feasible, a move away from traditional open resection was seen. Two multi-center randomized controlled trials in 2004 also showed a survival advantage with the addition of post-operative chemoradiotherapy in high-risk patients<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. Radiation-based approaches were adopted more commonly with surgery reserved for salvage. A report of the outcomes and complications comparing surgical and radiotherapy-based approaches in 2002 showed that while both approaches had similar survival and local control rates, surgery was associated with an increased rate of complications<sup><a href="#ref-7">7</a></sup>.</p></div><div class=section><a name=d12324e197 class=n-a></a><h3 class=section-title>Organ preservation era</h3><p class="" id=d12324e202>Landmark trials fueled the enthusiasm for organ preservation approaches in head and neck cancers and built upon increasing radiation treatment experience and expertise. In 1994, the Veterans Affair study reported outcomes for locally advanced laryngeal carcinoma treated with induction chemotherapy followed by radiotherapy (in responders) compared with total laryngectomy. The results of this study confirmed that a non-surgical organ preservation approach could be adopted, which achieved similar oncological outcomes but avoided laryngectomy in over 60% of cases. A further study in locally advanced laryngeal carcinoma by Forastiere <i>et al</i>. showed a survival benefit in the use of concomitant chemoradiotherapy (chemotherapy administered during radiation) over induction chemotherapy or radiation alone<sup><a href="#ref-8">8</a></sup>. These results were extrapolated to other head and neck sites and provided the initial support for organ preservation strategies. The first major OPSCC-specific trial was authored by the GORTEC group. They randomized 266 patients with OPSCC to concomitant chemoradiotherapy or radiotherapy alone<sup><a href="#ref-9">9</a></sup>. An overall survival at 3 years was reported as 51% in the chemoradiotherapy group versus 31% for the radiotherapy-alone group<sup><a href="#ref-9">9</a></sup>. At 5 years, a 6.6% overall survival benefit with the addition of chemotherapy was reported<sup><a href="#ref-10">10</a></sup>. This has subsequently become a standard therapy for loco-regional advanced OPSCC and was supported by a robust meta-analysis<sup><a href="#ref-11">11</a></sup>.</p></div><div class=section><a name=d12324e230 class=n-a></a><h3 class=section-title>Improvements in radiation</h3><p class="" id=d12324e235>Further interest in radiation treatments for OPSCC was stimulated by advancing technologies in the delivery of radiotherapy. Intensity-modulated radiotherapy treatment (IMRT) was introduced in the early 2000s. This was a new radiotherapy technique aimed at reducing the comorbidity of treatment by allowing the oncologist to manipulate radiation dose in a way that would increase accuracy and reduce the dose to bystander structures. Specific potential advantages of this targeted method of delivering radiation include avoidance of high-dose exposure to the parotid glands to minimize xerostomia<sup><a href="#ref-12">12</a></sup> and to the pharyngeal constrictors in an attempt to minimize swallowing dysfunction<sup><a href="#ref-13">13</a></sup>.</p></div><div class=section><a name=d12324e247 class=n-a></a><h3 class=section-title>Human papillomavirus era</h3><p class="" id=d12324e252>The next major development was the discovery of a viral etiological agent in the carcinogenesis of OPSCC. An association of HPV with carcinomas of the tonsil and base of the tongue emerged in the early 1990s, with the identification of HPV DNA in tumor cell nuclei and viral oncogene transcription in tonsillar carcinomas<sup><a href="#ref-14">14</a></sup>. This coincided with changes in the incidence and demographics of OPSCC<sup><a href="#ref-15">15</a></sup>. The incidence of tonsillar carcinomas in the United States increased by 1.9% and 2.7% per year from 1973 to 1995 in Caucasian and African-American men, respectively, while all other oral sites remained constant. The impact and relevance of these discoveries were crystallized by Kian Ang <i>et al</i>. in 2010<sup><a href="#ref-16">16</a></sup>. They reported a retrospective analysis of the association between tumor HPV status and survival among patients with stage III or IV OPSCC. In 323 patients, HPV was detected in 206 tumors (63.8%). The HPV-positive tumors had a better 3-year overall survival (82.4% versus 57.1%, <i>p</i>&lt;0.001) and, after adjustment for age, race, tumor and nodal stage, tobacco exposure, and treatment assignment, had a 58% reduction in the risk of death (hazard ratio 0.42; 95% confidence interval [CI] 0.270.66). The effect of HPV status on outcome has now been shown in many series throughout the world. A meta-analysis of studies worldwide reporting on 5,681 patients showed the prevalence of HPV tumors was 22% and this was associated with an improved survival, with HPV-positive tumors having a 68% reduced risk of death compared to HPV-negative tumors (hazard ratio 0.42, 95% CI 0.270.57)<sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d12324e278>The proportion of OPSCC with detectable HPV DNA on testing approached 50% in a number of series<sup><a href="#ref-14">14</a></sup>, but the rate does vary by country. A UK series has shown up to 70% of oropharyngeal tumors are HPV related<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. The HPV16 subtype is the most common and is found in 90% of tumors. The other high-risk subtypes 31, 33, and 18 have also been identified<sup><a href="#ref-14">14</a></sup>. In an East-Denmark study between 2000 and 2010, Garns <i>et al</i>. found 58% of tonsillar OPSCC were HPV-related tumors and 51% in the base of the tongue were also HPV related<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. However, high-risk HPV DNA showing evidence of transcription is infrequently seen at other sites in the head and neck and at the subsites of the soft palate and posterior pharynx<sup><a href="#ref-18">18</a></sup>. A multicenter cross-sectional retrospective study in the UK, however, has confirmed an increase in OPSCC cases but also showed that the percentage of tumors that were HPV related remained static<sup><a href="#ref-22">22</a></sup>.</p><p class="" id=d12324e315>This difference in anatomical location has allowed for the investigation of population-level data<sup><a href="#ref-23">23</a></sup>. An analysis of Surveillance, Epidemiology, and End Results (SEER) data from 1973 to 2004 with patients deemed likely to be HPV positive based on if the tumors location was in the tonsil or the base of the tongue showed patients were younger (61.0 versus 63.8 years, <i>p&lt;</i>0.001)<sup><a href="#ref-23">23</a></sup>. A series of 193 patients, using DNA PCR to test for HPV, showed that HPV-positive tumors were more likely to affect patients younger than 55 years old<sup><a href="#ref-24">24</a></sup>. Age was recognized as an important distinction between HPV-positive and -negative tumors in a study from Sweden<sup><a href="#ref-25">25</a></sup>. Patients with HPV-related cancers were younger (mean age of 59 years [range 4278] versus 66 years [range 4589]).</p><p class="" id=d12324e337>Additionally, USA SEER data indicated that men have a higher incidence of OPSCC than do women and that blacks are more commonly affected<sup><a href="#ref-23">23</a></sup>. However, when likely HPV-positive tumors are examined, they were seen to have a higher incidence in white men and an increasing incidence in men in all other races<sup><a href="#ref-23">23</a></sup>. There was also a correlation between the educated middle class and HPV-positive cancers<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d12324e353>Other differences between HPV-positive and -negative tumors have also been seen. Tobacco has been identified as a head and neck cancer risk factor; it also acts synergistically with alcohol<sup><a href="#ref-26">26</a></sup>. A 25,500-patient multicenter study found that tobacco is a major risk factor for head and neck and oropharynx carcinoma<sup><a href="#ref-27">27</a></sup>. Patients with HPV-positive tumors have been shown to be non-smokers more often<sup><a href="#ref-28">28</a></sup>, and the overall tobacco use is lower compared to that in HPV-negative patients. However, smoking is still a risk factor but has less of an impact in HPV-related cancers. Patients with HPV-positive tumors have about 30% non-smokers in their group compared with less than 5% in the HPV-negative groups<sup><a href="#ref-29">29</a></sup>. This relationship has been seen in a number of studies<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d12324e376>The majority of studies that supported the use of chemoradiotherapy in patients with OPSCC were performed in the 1990s and early 2000s. At this time, the link between HPV and OPSCC was being uncovered. Unfortunately, it has not been possible to retrospectively analyze the patients in these studies to understand what proportion of these tumors were HPV related.</p><p class="" id=d12324e379>Other differences are also seen in the clinical presentation of HPV-related OPSCC. They tend to have smaller primary T stage<sup><a href="#ref-31">31</a></sup> tumors with larger cervical nodal disease<sup><a href="#ref-32">32</a></sup>. The nodal disease is often also cystic. However, despite presenting with advanced nodal disease, which is traditionally thought to be associated with poor outcome, they are associated with an improved prognosis. This means HPV status could have acted as a confounder in studies that have not stratified for HPV status. The recurrence and failure rates are lower in the doubly positive HPV/p16 tumors compared to the HPV/p16-negative tumors<sup><a href="#ref-33">33</a></sup>. Other important differences in risk factors for HPV-related carcinoma compared to non-HPV-related OPSCC are the male preponderance and sexual exposure<sup><a href="#ref-34">34</a></sup>. Recognition of the major differences in risk factors, demographics, clinical behavior, and response to treatment of HPV-positive compared to HPV-negative tumors<sup><a href="#ref-16">16</a>,<a href="#ref-35">35</a></sup> may allow more tailored treatment.</p></div><div class=section><a name=d12324e407 class=n-a></a><h3 class=section-title>Treatment trends and outcomes</h3><p class="" id=d12324e412>In a study using the National Cancer Database (NCDB), a North American governmental database of cancers and treatments, the trends in the treatment modalities used in OPSCC were examined<sup><a href="#ref-36">36</a></sup>. In an analysis of 43,983 patients between 1998 and 2009, the number of patients receiving chemoradiation increased from 22% of all patients in 1998 to 61% in 2009. This has been accompanied by a concurrent decline in the percentage of patients receiving surgery, from 41% in 1998 to 31% in 2009. This coincides with the increasing incidence of OPSCC and increased HPV-related disease.</p><p class="" id=d12324e419>In recent studies using modern IMRT techniques, outcomes of chemoradiation for OPSCC have been excellent. In a European study<sup><a href="#ref-37">37</a></sup> analyzing the survival and toxicity outcomes with primary IMRT, 186 patients received IMRT with 90% of loco-regionally advanced disease receiving concurrent chemotherapy or cetuximab. The estimated 3-year overall survival (OS), disease-free survival (DFS), and disease-specific survival (DSS) rates were 77.2% (70.583.9), 72.3% (65.479.2), and 80.2% (74.186.3), respectively. Estimated 3-year OS, DFS, and DSS rates for HPV-positive patients were 90.9% (85.296.6), 87.9% (81.494.4), and 91.8% (86.397.3), respectively.</p><p class="" id=d12324e426>Despite the excellent oncological results achieved with this approach, the changing demographic of patients with OPSCC and the improvement in survival means new challenges are being seen. The complications and sequelae of treatment are now more pertinent because patients are younger, more likely to be cured, and more likely to live longer.</p><p class="" id=d12324e429>Bird <i>et al</i>.<sup><a href="#ref-37">37</a></sup> reported that three (1.6%) patients died during or within 30 days of radiation completion, 74 (40%) were admitted at least once during their radiotherapy, and 76% needed a feeding tube either as a supplement to their oral intake or to meet their complete nutritional requirements. However, long-term toxicities are likely to be more important in understanding which treatment is best for patients, as all treatment approaches are associated with acute toxicity.</p></div><div class=section><a name=d12324e440 class=n-a></a><h3 class=section-title>Minimally invasive surgery era</h3><p class="" id=d12324e445>Our understanding of OPSCC etiology and its relationship with HPV infection has evolved at a time when non-surgical organ preservation approaches in head and neck oncology have replaced more traditional open surgeries with post-operative radiotherapy. However, over a similar time frame, significant progress has been made in surgical technology. Advances in optics and instrumentation have made a number of options available for the removal of head and neck cancers via a trans-oral endoscopic route. Trans-oral laser techniques have long been used in the larynx, and similar approaches have been adapted to use in the oropharynx<sup><a href="#ref-38">38</a></sup>. However, access can be challenging, particularly to the posterior tongue base. Since the US Food and Drug Administrations (FDA) approval of trans-oral robotic surgery (TORS), robotic surgery has offered a minimally invasive approach for head and neck tumors. The da Vinci robot (Intuitive Surgical Inc, Sunnyvale, CA, USA) began its development in urology and cardiac surgery. In 2005, Melder and McLeod reported its first use in head and neck surgery when they performed a resection of a vallecular cyst<sup><a href="#ref-39">39</a></sup>. In 2006, Weinstein <i>et al</i>. at the University of Pennsylvania reported the robots first application to head and neck malignancy<sup><a href="#ref-40">40</a></sup>; their group conducted most of its early research and coined the term TORS. Subsequently, in 2009, the FDA approved its use in the head and neck, and TORS is now utilized worldwide.</p><p class="" id=d12324e463>Trans-oral surgery has emerged as an approach that offers an alternative to open surgery and primary non-surgical treatments and is being used in the staging/diagnosis of unknown primary patients<sup><a href="#ref-41">41</a></sup>. The advantages of TORS are the ability to operate without line-of-sight restrictions that limit other trans-oral endoscopic or microscopic approaches<sup><a href="#ref-42">42</a></sup>. The approach offers a consistent approach in which the pharyngeal muscle constrictors are removed to provide a deep margin. It allows tumors that would normally demand a pharyngotomy or mandibulotomy to be resected. Additionally, it involves instruments with six degrees of freedom, motion scaling, instrument stabilization, and tremor reduction<sup><a href="#ref-43">43</a></sup>. Precise three-dimensional visualization is aided by binocular and magnified endoscopic vision. Trans-oral microsurgery offers a different philosophy which was initially popularized by Steiner<sup><a href="#ref-44">44</a></sup>, with some centers reproducing excellent results with the technique<sup><a href="#ref-38">38</a>,<a href="#ref-45">45</a></sup>. A bespoke tumor resection is performed in which the deep margin is assessed using the microscope and tissue characteristics during resection. The tumor may be carefully divided to allow removal and resection in different sections. Careful histopathological analysis is required to understand where the true margin of the tumor is.</p><p class="" id=d12324e489>Trans-oral laser microsurgery (TLM) and TORS have demonstrated excellent oncological results for many indications and subsites, mostly in single institutional studies and oropharyngeal disease<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. TORS has also shown promising functional outcomes with appropriate adjuvant therapy<sup><a href="#ref-48">48</a></sup>. A multi-institutional study of TORS has recently reported a 3-year survival rate of 92.5% and a 3-year recurrence rate of 88.8%<sup><a href="#ref-49">49</a></sup>.</p></div><div class=section><a name=d12324e508 class=n-a></a><h3 class=section-title>Immunotherapy era</h3><p class="" id=d12324e513>The most recent development in the treatment of head and neck cancer is immunotherapy. Significant progress has been made in the application of immune checkpoint inhibitors such as nivolumab, pembrolizumab, durvalumab, atezolizumab, and avelumab. The checkpoint inhibitors pembrolizumab and nivolumab are FDA approved in the recurrent and metastatic setting and have an established paradigm for use. The majority of current studies are assessing drugs in the end-stage setting and also using a combination of treatments<sup><a href="#ref-50">50</a></sup>. However, there are currently 16 trials exploring the use of these drugs in the primary setting with curative intent.</p><p class="" id=d12324e520>A majority of these drugs act on the PD1 (programmed cell death protein)/PDL1 axis. This is applicable to head and neck and OPSCC because the oropharynx is known to be an immune-privileged site. The reticulated epithelium is known to express the immune checkpoint ligand PDL1, and the resulting reduction in cytotoxic T cell response has been linked to persistent HPV infection at these sites<sup><a href="#ref-51">51</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12324e531>Current treatments and trials</h2><div class=section><a name=d12324e534 class=n-a></a><h3 class=section-title>Current treatment options</h3><p class="" id=d12324e539>Despite major differences in the risk factors, demographics, clinical behavior, response to treatment, and molecular patterns of HPV-positive compared to HPV-negative tumors<sup><a href="#ref-16">16</a>,<a href="#ref-35">35</a></sup>, the recommended treatment options are still the same, unless the patient is on a trial. Treatment is decided using the Tumor, Node, Metastasis (TNM) stage, the patients preferences, the patients co-morbidities, and the physicians experience<sup><a href="#ref-26">26</a></sup>. For loco-regionally advanced oropharyngeal cancer, dual modality treatment with either trans-oral surgery and post-operative radiotherapy with or without post-operative chemotherapy or concurrent chemoradiotherapy is usually offered. In cancers of the tonsil and base of the tongue, chemoradiotherapy is used more frequently<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. Early stage disease can be treated with single modality treatment, such as surgery or radiotherapy alone.</p><p class="" id=d12324e560>The long-term toxicities following chemoradiotherapy have been questioned<sup><a href="#ref-54">54</a></sup> and have provided impetus and enthusiasm for trans-oral resection as a primary treatment for these tumors<sup><a href="#ref-55">55</a></sup>. There are no randomized trials comparing trans-oral approaches versus IMRT, and the majority of the literature is limited to uncontrolled reports<sup><a href="#ref-56">56</a></sup>. Comparable oncologic outcomes with TORS compared to IMRT have been reported in these studies and functional outcomes <i>may</i> be superior. However, current follow-up is relatively short, and the TORS studies include patients with earlier-stage OPSCC on average compared to comparable IMRT studies.</p></div><div class=section><a name=d12324e579 class=n-a></a><h3 class=section-title>Current trials in OPSCC</h3><p class="" id=d12324e584>The use of surgery in HPV-positive oropharyngeal cancer and the application of minimally invasive techniques to avoid or reduce required doses of adjuvant treatment have become important areas of study<sup><a href="#ref-57">57</a></sup>. Trans-oral laser surgery (TLS) was first popularized by Steiner in Germany<sup><a href="#ref-44">44</a></sup>. There has been increasing experience with TLS, but its use for oropharyngeal tumors has been limited to a few high-volume centers in the USA<sup><a href="#ref-58">58</a></sup> and European units in the UK, France, and Germany<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d12324e603>De-escalation based on surgical resection and the neck stage is being assessed in HPV-positive tumors In the Sinai Robotic Surgery Trial (NCT02072148). Another study, conducted at the University of Pennsylvania, is employing robotic surgery to de-escalate adjuvant treatment. Reduced treatment to the primary tumor bed in fully resected tumors (NCT02225496) is being investigated. The Eastern Cooperative Oncology Group (ECOG) 3311 study is a large, randomized, multicenter study comparing normal-dose post-operative radiation with low-dose treatment (NCT01898494) following minimally invasive surgery; patients are stratified post-operatively, with low-risk patients being observed, high-risk patients receiving chemoradiotherapy, and intermediate-risk patients being randomized to normal or low standard-dose radiotherapy.</p><p class="" id=d12324e606>The PATHOS trial (Post-operative Adjuvant Treatment for HPV-positive Tumors) is a UK-based multicenter randomized trial. It is comparing post-operative treatment for HPV-positive disease. With pathological information from the surgical resection, patients will be classified as low, intermediate, or high risk. Patients who are low risk will be observed without adjuvant treatment. Patients who are intermediate and high risk will be randomized to an adjuvant treatment. The intermediate-risk group will be randomized to either high-dose or low-dose radiation and the high-risk group to standard radiotherapy either with or without chemotherapy (NCT02215265).</p><p class="" id=d12324e609>The ADEPT trial (Post-Operative Adjuvant Therapy De-intensification Trial for HPV-related, p16+ Oropharynx Cancer) examined patients with fully excised HPV-positive tumors and randomized patients to either radiotherapy or radiotherapy plus cisplatin (NCT01687413). It is now closed to accrual. The use of post-operative docetaxel with hyper-fractioned IMRT is being investigated in another trial following minimally invasive surgery (NCT01932697). In the Canadian ORATOR trial, a phase II randomized trial, patients with early stage OPSCC were randomized to receive radiotherapy or trans-oral robotic surgery with neck dissection (NCT01590355). In this best of randomized study, patient-reported swallowing function over the first year will be investigated following allocation to either IMRT or TORS in patients with early stage OPSCC (NCT02984410).</p><p class="" id=d12324e613>There are a number of other trials that are using modification of the standard radiotherapy or chemotherapy techniques. In HPV-positive oropharyngeal tumors, cisplatin alternatives are being trialed, as they are thought to have less toxicity. With concurrent radiation, epidermal growth factor receptor (EGFR) therapies are being investigated. Cetuximab is the most common agent. It is a monoclonal antibody that targets the EGFR extracellular ligand-binding domain on the cell surface.</p><p class="" id=d12324e616>The Radiation Therapy Oncology Group (RTOG) are conducting a randomized trial of cisplatin versus cetuximab with radiation (NCT01302834). De-ESCALaTE (Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events) is a UK trial comparing either cisplatin or cetuximab with radiation and using toxicity as a primary outcome (NCT01874171). Also, the Australian Trans-Tasman Radiation Oncology Group (TROG) have a trial comparing cetuximab to cisplatin with radiotherapy (NCT01855451). An additional study is investigating cetuximab with pre- and post-treatment biopsies, which will then be compared to a historical series of cisplatin-treated patients (NCT01663259).</p><p class="" id=d12324e619>Reducing or modulating the radiation dose following induction chemotherapy is another strategy. In a RTOG trial, depending on how patients respond to induction chemotherapy with paclitaxel, cisplatin, and cetuximab, cetuximab combined with either low- or standard-dose IMRT will be administered (NCT01084083). The Quarterback Trial (NCT01706939) compares a decreased radiation dose with weekly carboplatin to a standard radiation regimen with weekly carboplatin following induction chemotherapy in patients with a good response. Also, the OPTIMA trial is investigating de-intensifying treatment based on response to induction chemotherapy. Using nab-paclitaxel and carboplatin as an induction regimen, the investigators will administer a response-based therapy. Chemotherapy with high- or low-dose radiation or just radiation alone is being investigated in stage III or IV HPV-related OPSCC (NCT02258659). Paclitaxel and carboplatin used as an induction therapy with concomitant paclitaxel in tumors of HPV-positive patients is another regimen under investigation (NCT02048020).</p><p class="" id=d12324e622>In HPV-positive patients, reducing the radiation dose is another approach. Reduction of the dose of IMRT to 5460 Gy while simultaneously administering weekly intravenous cisplatin will precede surgical resection of any clinically apparent residual tumor or neck disease (NCT01530997).</p><p class="" id=d12324e625>A randomized trial of HPV-positive oropharynx tumors using a reduced dose of IMRT treatment with randomization to radiotherapy alone or concomitant cisplatin presents an additional approach (NCT02254278). Treatment de-intensification is being investigated in another study alongside cisplatin chemotherapy with a reduced radiation dose, with the experimental arms dose decreasing from 70 Gy to 63 Gy (NCT01088802).</p><p class="" id=d12324e628>There are other new agents and immune therapies currently being trialed. Ribavirin is being evaluated as part of a phase I trial. It is a drug that is used in the treatment of hepatitis C, and it is being used with afatinib (a tyrosine kinase inhibitor) as an induction chemotherapy agent with weekly carboplatin/paclitaxel dose (NCT01721525).</p><p class="" id=d12324e632>Immune therapy and vaccines are thought to offer an additional modality of treatment because foreign viral antigens could be amenable to targeted therapy. The local presence of HPV16-specific T cell immunity found in HPV16-induced SCC suggests a basis for this<sup><a href="#ref-59">59</a></sup>.</p><p class="" id=d12324e639>The use of T cells as an autologous transfusion is a process termed adoptive immunotherapy. Other highly immunogenic tumors such as melanoma have responded to this type of therapy<sup><a href="#ref-60">60</a></sup>, and it is now being investigated in the head and neck.</p><p class="" id=d12324e646>Antitumor vaccines are a different immune-modulating therapy aiming to stimulate a hosts immune system in the treatment of cancer. In a phase I trial, recombinant <i>Listeria monocytogenes</i> is the base for a vaccine that has been modified to express HPV16 targets (REALISTIC trial). This trial was closed early.</p><p class="" id=d12324e652>In contrast to efforts to de-escalate treatment of HPV-positive low-risk tumors, HPV-negative tumors and some HPV-positive tumors in patients with a smoking and alcohol history are deemed high risk. In these patients, there may be benefit in escalating treatment to improve outcomes. In the COMPARE trial (UKCRN Study ID: 18621), additional treatments in conjunction with standard chemoradiotherapy are being investigated compared to standard chemoradiotherapy. Patients are randomized to either the standard or receive surgery followed by chemoradiotherapy, more chemotherapy as induction (docetaxel, cisplatin, and 5-fluorouracil), a higher dose of radiotherapy as part of their chemoradiotherapy, or durvalumab with chemoradiotherapy.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12324e659>Changes in testing and staging</h2><div class=section><a name=d12324e662 class=n-a></a><h3 class=section-title>Testing for human papillomavirus</h3><p class="" id=d12324e667>There has been controversy regarding the different techniques and biomarkers used to determine whether a tumor is related to HPV infection. Sustained and persistent high-risk HPV E6/E7 viral oncogene expression is essential for a HPV-driven malignant tumor<sup><a href="#ref-53">53</a></sup>. The detection of HPV E6/E7 mRNA transcripts correlates with cellular genotoxic damage and gene expression changes that are the hallmarks of cancer. However, the detection of mRNA in the clinical setting is difficult and expensive<sup><a href="#ref-61">61</a></sup>. Another approach is using p16 as a surrogate for HPV infection and could utilize the cheaper and more available immunohistochemistry stains. However, when a number of these different assays were tested, only the RT-PCR assay for HPV16 E6*I mRNA developed specifically for formalin-fixed paraffin-embedded (FFPE) material was able to accurately classify samples<sup><a href="#ref-62">62</a></sup>. Using the different biomarkers for prediction of outcome, the doubly positive p16/HPV DNA test had the best predictive ability, with p16-positive/HPV-negative tumors having a prognosis closer to more typical non-HPV-related tumors<sup><a href="#ref-33">33</a></sup>. Therefore, it has been proposed that the combination of p16 immunohistochemistry and the detection of HPV DNA by PCR is required<sup><a href="#ref-63">63</a></sup>. Other testing methods for HPV infection involve the use of saliva samples from swish and spit specimens<sup><a href="#ref-64">64</a></sup>. This may provide a potential screening test for OPSCC or may replace the need for formal biopsy<sup><a href="#ref-65">65</a></sup>.</p></div><div class=section><a name=d12324e700 class=n-a></a><h3 class=section-title>Union for International Cancer Control/American Joint Committee on Cancer Tumor, Node, Metastasis staging system eighth edition</h3><p class="" id=d12324e705>Another recent change has been the introduction of an updated staging system for OPSCC. The eighth edition of the Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) TNM system was introduced into clinical practice in January 2018. However, the current UK policy is to not use the TNM eighth edition for treatment allocation. The data used to revise the system are largely retrospective and therefore treatment de-intensification should currently only occur in the context of an appropriate clinical trial.</p><p class="" id=d12324e708>OPSCC has been divided into p16-positive, high-risk HPV-associated tumors and p16-negative tumors<sup><a href="#ref-66">66</a></sup>. In the T staging category, the Tis and T4b stages have been removed from HPV-related tumors. There has been the introduction of separate clinical and pathological N staging systems. The clinical N staging has been simplified, with the N1 stage now including all patients with ipsilateral nodes less than 6 cm. This will downstage patients who previously had T2b neck disease in the seventh edition. N2 disease includes patients with contralateral or bilateral disease, and N3 is for patients with a neck mass of more than 6 cm. In the pathological staging system, N1 disease is fewer than four positive nodes, N2 is more than four positive nodes, and N3 has been removed.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12324e719>Conclusion</h2><p class="" id=d12324e722>OPSCC is an evolving field. For many years, surgery and radiation therapy were the only options for treatment in the majority of cases. While this is still true, a number of new and exciting options are becoming available. Advances in radiotherapy techniques and the introduction of IMRT allow more accurate dose delivery to the tumor while sparing surrounding structures to minimize side effects. Improvements in our understanding of the biology of HPV-related disease have led to attempts to de-intensify treatment regimens to further reduce the morbidity of therapy in low-risk patients. Surgical techniques have incorporated state-of-the-art technology, such as new robotic and laser systems. These advances offer the potential to reduce the long-term morbidity associated with chemoradiation and may also play a role in the intensification of treatment for the highest-risk HPV-negative patients. There is also a whole new modality, immune therapy, with new drugs receiving FDA approval in the setting of recurrent/metastatic head and neck cancers. It seems likely that, over the next decade, we will see a move away from standard chemoradiotherapy techniques to a more individualized approach based on the patient and tumor factors in an attempt to optimize oncological outcome while minimizing morbidity for a growing number of patients with OPSCC. Other changes have emerged as our understanding of HPV-related tumors has improved. This is particularly shown with the introduction of the new TNM eighth edition staging system.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d12324e1 class=n-a></a><h2 class=main-title id=d12560>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d12324e729 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d12776>References</h2><div class="section ref-list"><a name=d12324e729 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d12324e736 class=n-a></a>Amin MB, American Join Committee on C: AJCC cancer staging manual. Eigthedition. ed. Chicago: American Joint Committee on Cancer/Springer; 2017. xvii, 1024 pages: illustrations (some colour); 29 cm. p. <a target=xrefwindow id=d12324e738 href="https://cancerstaging.org/references-tools/deskreferences/Pages/default.aspx">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733843790"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e747 class=n-a></a>Stevens TM, Bishop JA: HPV-related carcinomas of the head and neck: Morphologic features, variants, and practical considerations for the surgical pathologist. <i>Virchows Arch.</i> 2017; <b>471</b>(2): 295307. <a target=xrefwindow id=d12324e755 href="http://www.ncbi.nlm.nih.gov/pubmed/28417200">PubMed Abstract </a> | <a target=xrefwindow id=d12324e758 href="http://dx.doi.org/10.1007/s00428-017-2118-y">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733843790">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d12324e771 class=n-a></a>Best SR, Niparko KJ, Pai SI: Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. <i>Otolaryngol Clin North Am.</i> 2012; <b>45</b>(4): 80722. <a target=xrefwindow id=d12324e779 href="http://www.ncbi.nlm.nih.gov/pubmed/22793854">PubMed Abstract </a> | <a target=xrefwindow id=d12324e782 href="http://dx.doi.org/10.1016/j.otc.2012.04.005">Publisher Full Text </a> | <a target=xrefwindow id=d12324e785 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3398423">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d12324e794 class=n-a></a>Rothman K, Keller A: The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. <i>J Chronic Dis.</i> 1972; <b>25</b>(12): 7116. <a target=xrefwindow id=d12324e802 href="http://www.ncbi.nlm.nih.gov/pubmed/4648515">PubMed Abstract </a> | <a target=xrefwindow id=d12324e805 href="http://dx.doi.org/10.1016/0021-9681(72)90006-9">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d12324e814 class=n-a></a>Bernier J, Domenge C, Ozsahin M, <i> et al.</i>: Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. <i>N Engl J Med.</i> 2004; <b>350</b>(19): 194552. <a target=xrefwindow id=d12324e825 href="http://www.ncbi.nlm.nih.gov/pubmed/15128894">PubMed Abstract </a> | <a target=xrefwindow id=d12324e828 href="http://dx.doi.org/10.1056/NEJMoa032641">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d12324e838 class=n-a></a>Cooper JS, Pajak TF, Forastiere AA, <i> et al.</i>: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. <i>N Engl J Med.</i> 2004; <b>350</b>(19): 193744. <a target=xrefwindow id=d12324e849 href="http://www.ncbi.nlm.nih.gov/pubmed/15128893">PubMed Abstract </a> | <a target=xrefwindow id=d12324e852 href="http://dx.doi.org/10.1056/NEJMoa032646">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d12324e861 class=n-a></a>Parsons JT, Mendenhall WM, Stringer SP, <i> et al.</i>: Squamous cell carcinoma of the oropharynx: Surgery, radiation therapy, or both. <i>Cancer.</i> 2002; <b>94</b>(1): 296780. <a target=xrefwindow id=d12324e872 href="http://www.ncbi.nlm.nih.gov/pubmed/12115386">PubMed Abstract </a> | <a target=xrefwindow id=d12324e875 href="http://dx.doi.org/10.1002/cncr.10567">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d12324e884 class=n-a></a>Forastiere AA, Goepfert H, Maor M, <i> et al.</i>: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. <i>N Engl J Med.</i> 2003; <b>349</b>(22): 20918. <a target=xrefwindow id=d12324e895 href="http://www.ncbi.nlm.nih.gov/pubmed/14645636">PubMed Abstract </a> | <a target=xrefwindow id=d12324e898 href="http://dx.doi.org/10.1056/NEJMoa031317">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d12324e907 class=n-a></a>Calais G, Alfonsi M, Bardet E, <i> et al.</i>: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. <i>J Natl Cancer Inst.</i> 1999; <b>91</b>(24): 20816. <a target=xrefwindow id=d12324e918 href="http://www.ncbi.nlm.nih.gov/pubmed/10601378">PubMed Abstract </a> | <a target=xrefwindow id=d12324e921 href="http://dx.doi.org/10.1093/jnci/91.24.2081">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d12324e930 class=n-a></a>Denis F, Garaud P, Bardet E, <i> et al.</i>: Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. <i>J Clin Oncol.</i> 2004; <b>22</b>(1): 6976. <a target=xrefwindow id=d12324e941 href="http://www.ncbi.nlm.nih.gov/pubmed/14657228">PubMed Abstract </a> | <a target=xrefwindow id=d12324e944 href="http://dx.doi.org/10.1200/JCO.2004.08.021">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d12324e953 class=n-a></a>Pignon JP, Bourhis J, Domenge C, <i> et al.</i>: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. <i>Lancet.</i> 2000; <b>355</b>(9208): 94955. <a target=xrefwindow id=d12324e964 href="http://www.ncbi.nlm.nih.gov/pubmed/10768432">PubMed Abstract </a> | <a target=xrefwindow id=d12324e967 href="http://dx.doi.org/10.1016/S0140-6736(00)90011-4">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9952956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e977 class=n-a></a>Nutting CM, Morden JP, Harrington KJ, <i> et al.</i>: Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. <i>Lancet Oncol.</i> 2011; <b>12</b>(2): 12736. <a target=xrefwindow id=d12324e988 href="http://www.ncbi.nlm.nih.gov/pubmed/21236730">PubMed Abstract </a> | <a target=xrefwindow id=d12324e991 href="http://dx.doi.org/10.1016/S1470-2045(10)70290-4">Publisher Full Text </a> | <a target=xrefwindow id=d12324e995 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3033533">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9952956">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726822645"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e1008 class=n-a></a>Petkar I, Rooney K, Roe JW, <i> et al.</i>: DARS: A phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. <i>BMC Cancer.</i> 2016; <b>16</b>(1): 770. <a target=xrefwindow id=d12324e1019 href="http://www.ncbi.nlm.nih.gov/pubmed/27716125">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1022 href="http://dx.doi.org/10.1186/s12885-016-2813-0">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1026 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5052945">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726822645">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d12324e1039 class=n-a></a>Gillison ML: Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. <i>Semin Oncol.</i> 2004; <b>31</b>(6): 74454. <a target=xrefwindow id=d12324e1047 href="http://www.ncbi.nlm.nih.gov/pubmed/15599852">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1050 href="http://dx.doi.org/10.1053/j.seminoncol.2004.09.011">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d12324e1059 class=n-a></a>Frisch M, Hjalgrim H, Jaeger AB, <i> et al.</i>: Changing patterns of tonsillar squamous cell carcinoma in the United States. <i>Cancer Causes Control.</i> 2000; <b>11</b>(6): 48995. <a target=xrefwindow id=d12324e1070 href="http://www.ncbi.nlm.nih.gov/pubmed/10880031">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1073 href="http://dx.doi.org/10.1023/A:1008918223334">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5113958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e1082 class=n-a></a>Ang KK, Harris J, Wheeler R, <i> et al.</i>: Human papillomavirus and survival of patients with oropharyngeal cancer. <i>N Engl J Med.</i> 2010; <b>363</b>(1): 2435. <a target=xrefwindow id=d12324e1093 href="http://www.ncbi.nlm.nih.gov/pubmed/20530316">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1096 href="http://dx.doi.org/10.1056/NEJMoa0912217">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1100 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2943767">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5113958">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d12324e1113 class=n-a></a>Dayyani F, Etzel CJ, Liu M, <i> et al.</i>: Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). <i>Head Neck Oncol.</i> 2010; <b>2</b>: 15. <a target=xrefwindow id=d12324e1124 href="http://www.ncbi.nlm.nih.gov/pubmed/20587061">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1127 href="http://dx.doi.org/10.1186/1758-3284-2-15">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1131 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2908081">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d12324e1141 class=n-a></a>Upile NS, Shaw RJ, Jones TM, <i> et al.</i>: Squamous cell carcinoma of the head and neck outside the oropharynx is rarely human papillomavirus related. <i>Laryngoscope.</i> 2014; <b>124</b>(12): 273944. <a target=xrefwindow id=d12324e1152 href="http://www.ncbi.nlm.nih.gov/pubmed/25042603">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1155 href="http://dx.doi.org/10.1002/lary.24828">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d12324e1164 class=n-a></a>Nsman A, Nordfors C, Holzhauser S, <i> et al.</i>: Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: A stabilisation of an epidemic of viral induced carcinoma? <i>Eur J Cancer.</i> 2015; <b>51</b>(1): 5561. <a target=xrefwindow id=d12324e1175 href="http://www.ncbi.nlm.nih.gov/pubmed/25466506">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1178 href="http://dx.doi.org/10.1016/j.ejca.2014.10.016">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d12324e1187 class=n-a></a>Garnaes E, Kiss K, Andersen L, <i> et al.</i>: A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date. <i>Int J Cancer.</i> 2015; <b>136</b>(9): 2196203. <a target=xrefwindow id=d12324e1198 href="http://www.ncbi.nlm.nih.gov/pubmed/25283302">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1201 href="http://dx.doi.org/10.1002/ijc.29254">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d12324e1210 class=n-a></a>Garnaes E, Kiss K, Andersen L, <i> et al.</i>: Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients. <i>Br J Cancer.</i> 2015; <b>113</b>(1): 1314. <a target=xrefwindow id=d12324e1221 href="http://www.ncbi.nlm.nih.gov/pubmed/26042932">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1224 href="http://dx.doi.org/10.1038/bjc.2015.198">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1228 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4647522">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726694381"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e1237 class=n-a></a>Schache AG, Powell NG, Cuschieri KS, <i> et al.</i>: HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology. <i>Cancer Res.</i> 2016; <b>76</b>(22): 6598606. <a target=xrefwindow id=d12324e1248 href="http://www.ncbi.nlm.nih.gov/pubmed/27569214">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1251 href="http://dx.doi.org/10.1158/0008-5472.CAN-16-0633">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726694381">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d12324e1264 class=n-a></a>Chaturvedi AK, Engels EA, Anderson WF, <i> et al.</i>: Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. <i>J Clin Oncol.</i> 2008; <b>26</b>(4): 6129. <a target=xrefwindow id=d12324e1275 href="http://www.ncbi.nlm.nih.gov/pubmed/18235120">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1278 href="http://dx.doi.org/10.1200/JCO.2007.14.1713">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d12324e1288 class=n-a></a>Smith EM, Ritchie JM, Summersgill KF, <i> et al.</i>: Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. <i>Int J Cancer.</i> 2004; <b>108</b>(5): 76672. <a target=xrefwindow id=d12324e1299 href="http://www.ncbi.nlm.nih.gov/pubmed/14696105">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1302 href="http://dx.doi.org/10.1002/ijc.11633">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d12324e1311 class=n-a></a>Mellin H, Friesland S, Lewensohn R, <i> et al.</i>: Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. <i>Int J Cancer.</i> 2000; <b>89</b>(3): 3004. <a target=xrefwindow id=d12324e1322 href="http://www.ncbi.nlm.nih.gov/pubmed/10861508">PubMed Abstract </a> | <a target="xrefwindow" id="d12324e1325" href="http://dx.doi.org/10.1002/1097-0215(20000520)89:3<300::AID-IJC14&gt;3.0.CO;2-G">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d12324e1334 class=n-a></a>Shah JP, Patel SG, Singh B: Jatin Shah's head and neck surgery and oncology. 4th ed. ed. Philadelphia, Pa: Elsevier/Mosby; 2012; viii, 838 p. : ill. (chiefly col.) ; 31 cm. p.<a target=xrefwindow id=d12324e1336 href="https://www.elsevier.com/books/jatin-shahs-head-and-neck-surgery-and-oncology/shah/978-0-323-05589-5">Reference Source</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d12324e1345 class=n-a></a>Winn DM, Lee YC, Hashibe M, <i> et al.</i>: The INHANCE consortium: Toward a better understanding of the causes and mechanisms of head and neck cancer. <i>Oral Dis.</i> 2015; <b>21</b>(6): 68593. <a target=xrefwindow id=d12324e1356 href="http://www.ncbi.nlm.nih.gov/pubmed/25809224">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1359 href="http://dx.doi.org/10.1111/odi.12342">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d12324e1368 class=n-a></a>Lindel K, Beer KT, Laissue J, <i> et al.</i>: Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma. <i>Cancer.</i> 2001; <b>92</b>(4): 80513. <a target=xrefwindow id=d12324e1379 href="http://www.ncbi.nlm.nih.gov/pubmed/11550151">PubMed Abstract </a> | <a target="xrefwindow" id="d12324e1382" href="http://dx.doi.org/10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386&gt;3.0.CO;2-9">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d12324e1391 class=n-a></a>Hong AM, Martin A, Chatfield M, <i> et al.</i>: Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. <i>Int J Cancer.</i> 2013; <b>132</b>(12): 274854. <a target=xrefwindow id=d12324e1402 href="http://www.ncbi.nlm.nih.gov/pubmed/23180456">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1405 href="http://dx.doi.org/10.1002/ijc.27956">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d12324e1415 class=n-a></a>Gillison ML, D'Souza G, Westra W, <i> et al.</i>: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. <i>J Natl Cancer Inst.</i> 2008; <b>100</b>(6): 40720. <a target=xrefwindow id=d12324e1426 href="http://www.ncbi.nlm.nih.gov/pubmed/18334711">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1429 href="http://dx.doi.org/10.1093/jnci/djn025">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718253960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e1438 class=n-a></a>Pytynia KB, Dahlstrom KR, Sturgis EM: Epidemiology of HPV-associated oropharyngeal cancer. <i>Oral Oncol.</i> 2014; <b>50</b>(5): 3806. <a target=xrefwindow id=d12324e1446 href="http://www.ncbi.nlm.nih.gov/pubmed/24461628">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1449 href="http://dx.doi.org/10.1016/j.oraloncology.2013.12.019">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1452 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4444216">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718253960">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d12324e1465 class=n-a></a>Goldenberg D, Begum S, Westra WH, <i> et al.</i>: Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. <i>Head Neck.</i> 2008; <b>30</b>(7): 898903. <a target=xrefwindow id=d12324e1476 href="http://www.ncbi.nlm.nih.gov/pubmed/18383529">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1479 href="http://dx.doi.org/10.1002/hed.20796">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726818264"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e1488 class=n-a></a>Larsen CG, Jensen DH, Carlander AL, <i> et al.</i>: Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: A population-based study of 1,542 consecutive patients. <i>Oncotarget.</i> 2016; <b>7</b>(44): 7176172. <a target=xrefwindow id=d12324e1499 href="http://www.ncbi.nlm.nih.gov/pubmed/27708214">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1502 href="http://dx.doi.org/10.18632/oncotarget.12335">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1506 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5342120">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726818264">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d12324e1519 class=n-a></a>Chung CH, Bagheri A, D'Souza G: Epidemiology of oral human papillomavirus infection. <i>Oral Oncol.</i> 2014; <b>50</b>(5): 3649. <a target=xrefwindow id=d12324e1527 href="http://www.ncbi.nlm.nih.gov/pubmed/24080455">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1530 href="http://dx.doi.org/10.1016/j.oraloncology.2013.09.003">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1533 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3968244">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d12324e1542 class=n-a></a>Iyer NG, Dogan S, Palmer F, <i> et al.</i>: Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer. <i>Ann Surg Oncol.</i> 2015; <b>22</b>(13): 441121. <a target=xrefwindow id=d12324e1553 href="http://www.ncbi.nlm.nih.gov/pubmed/25801358">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1556 href="http://dx.doi.org/10.1245/s10434-015-4525-0">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1560 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4986601">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d12324e1570 class=n-a></a>Chen AY, Zhu J, Fedewa S: Temporal trends in oropharyngeal cancer treatment and survival: 1998-2009. <i>Laryngoscope.</i> 2014; <b>124</b>(1): 1318. <a target=xrefwindow id=d12324e1578 href="http://www.ncbi.nlm.nih.gov/pubmed/23832649">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1581 href="http://dx.doi.org/10.1002/lary.24296">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726362744"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e1590 class=n-a></a>Bird T, De Felice F, Michaelidou A, <i> et al.</i>: Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma - a European singleinstitution analysis. <i>Clin Otolaryngol.</i> 2017; <b>42</b>(1): 11522. <a target=xrefwindow id=d12324e1601 href="http://www.ncbi.nlm.nih.gov/pubmed/27185284">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1604 href="http://dx.doi.org/10.1111/coa.12674">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726362744">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726264158"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e1617 class=n-a></a>Wilkie MD, Upile NS, Lau AS, <i> et al.</i>: Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach. <i>Head Neck.</i> 2016; <b>38</b>(8): 126370. <a target=xrefwindow id=d12324e1628 href="http://www.ncbi.nlm.nih.gov/pubmed/27042800">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1631 href="http://dx.doi.org/10.1002/hed.24432">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726264158">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d12324e1644 class=n-a></a>McLeod IK, Melder PC: Da Vinci robot-assisted excision of a vallecular cyst: A case report. <i>Ear Nose Throat J.</i> 2005; <b>84</b>(3): 1702. <a target=xrefwindow id=d12324e1652 href="http://www.ncbi.nlm.nih.gov/pubmed/15871586">PubMed Abstract </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d12324e1661 class=n-a></a>Weinstein GS, O'Malley BW, Snyder W, <i> et al.</i>: Transoral robotic surgery: Radical tonsillectomy. <i>Arch Otolaryngol Head Neck Surg.</i> 2007; <b>133</b>(12): 12206. <a target=xrefwindow id=d12324e1672 href="http://www.ncbi.nlm.nih.gov/pubmed/18086963">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1675 href="http://dx.doi.org/10.1001/archotol.133.12.1220">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d12324e1684 class=n-a></a>Channir HI, Rubek N, Nielsen HU, <i> et al.</i>: Transoral robotic surgery for the management of head and neck squamous cell carcinoma of unknown primary. <i>Acta Otolaryngol.</i> 2015; <b>135</b>(10): 10517. <a target=xrefwindow id=d12324e1695 href="http://www.ncbi.nlm.nih.gov/pubmed/26073750">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1698 href="http://dx.doi.org/10.3109/00016489.2015.1052983">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d12324e1708 class=n-a></a>Weinstein GS, O'Malley BW Jr, Magnuson JS, <i> et al.</i>: Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. <i>Laryngoscope.</i> 2012; <b>122</b>(8): 17017. <a target=xrefwindow id=d12324e1719 href="http://www.ncbi.nlm.nih.gov/pubmed/22752997">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1722 href="http://dx.doi.org/10.1002/lary.23294">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d12324e1731 class=n-a></a>Grillone GA, Jalisi S: Robotic Surgery of the Head and Neck. New York, NY: Springer New York; 2015. <a target=xrefwindow id=d12324e1733 href="http://dx.doi.org/10.1007/978-1-4939-1547-7">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d12324e1742 class=n-a></a>Steiner W: Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract. <i>Adv Otorhinolaryngol.</i> 1988; <b>39</b>: 13544. <a target=xrefwindow id=d12324e1750 href="http://www.ncbi.nlm.nih.gov/pubmed/2455969">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1753 href="http://dx.doi.org/10.1159/000415662">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d12324e1762 class=n-a></a>Rich JT, Liu J, Haughey BH: Swallowing function after transoral laser microsurgery (TLM)  adjuvant therapy for advanced-stage oropharyngeal cancer. <i>Laryngoscope.</i> 2011; <b>121</b>(11): 238190. <a target=xrefwindow id=d12324e1770 href="http://www.ncbi.nlm.nih.gov/pubmed/21882203">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1773 href="http://dx.doi.org/10.1002/lary.21406">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1776 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4201117">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d12324e1785 class=n-a></a>de Almeida JR, Byrd JK, Wu R, <i> et al.</i>: A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. <i>Laryngoscope.</i> 2014; <b>124</b>(9): 2096102. <a target=xrefwindow id=d12324e1796 href="http://www.ncbi.nlm.nih.gov/pubmed/24729006">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1799 href="http://dx.doi.org/10.1002/lary.24712">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d12324e1808 class=n-a></a>Kelly K, Johnson-Obaseki S, Lumingu J, <i> et al.</i>: Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review. <i>Oral Oncol.</i> 2014; <b>50</b>(8): 696703. <a target=xrefwindow id=d12324e1819 href="http://www.ncbi.nlm.nih.gov/pubmed/24917389">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1822 href="http://dx.doi.org/10.1016/j.oraloncology.2014.04.005">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d12324e1832 class=n-a></a>Hutcheson KA, Holsinger FC, Kupferman ME, <i> et al.</i>: Functional outcomes after TORS for oropharyngeal cancer: a systematic review. <i>Eur Arch Otorhinolaryngol.</i> 2015; <b>272</b>(2): 46371. <a target=xrefwindow id=d12324e1843 href="http://www.ncbi.nlm.nih.gov/pubmed/24643851">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1846 href="http://dx.doi.org/10.1007/s00405-014-2985-7">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1850 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4169348">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d12324e1859 class=n-a></a>de Almeida JR, Li R, Magnuson JS, <i> et al.</i>: Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study. <i>JAMA Otolaryngol Head Neck Surg.</i> 2015; <b>141</b>(12): 104351. <a target=xrefwindow id=d12324e1870 href="http://www.ncbi.nlm.nih.gov/pubmed/26402479">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1873 href="http://dx.doi.org/10.1001/jamaoto.2015.1508">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1877 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5019351">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727579779"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e1886 class=n-a></a>Dogan V, Rieckmann T, Mnscher A, <i> et al.</i>: Current studies of immunotherapy in head and neck cancer. <i>Clin Otolaryngol.</i> 2018; <b>43</b>(1): 1321. <a target=xrefwindow id=d12324e1897 href="http://www.ncbi.nlm.nih.gov/pubmed/28464441">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1900 href="http://dx.doi.org/10.1111/coa.12895">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727579779">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d12324e1913 class=n-a></a>Lyford-Pike S, Peng S, Young GD, <i> et al.</i>: Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. <i>Cancer Res.</i> 2013; <b>73</b>(6): 173341. <a target=xrefwindow id=d12324e1924 href="http://www.ncbi.nlm.nih.gov/pubmed/23288508">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1927 href="http://dx.doi.org/10.1158/0008-5472.CAN-12-2384">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3602406">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d12324e1940 class=n-a></a>Calais G, Alfonsi M, Bardet E, <i> et al.</i>: [Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy]. <i>Bull Cancer.</i> 2000; <b>87 Spec No</b>: 4853. <a target=xrefwindow id=d12324e1951 href="http://www.ncbi.nlm.nih.gov/pubmed/11082723">PubMed Abstract </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d12324e1960 class=n-a></a>Marur S, D'Souza G, Westra WH, <i> et al.</i>: HPV-associated head and neck cancer: a virus-related cancer epidemic. <i>Lancet Oncol.</i> 2010; <b>11</b>(8): 7819. <a target=xrefwindow id=d12324e1971 href="http://www.ncbi.nlm.nih.gov/pubmed/20451455">PubMed Abstract </a> | <a target=xrefwindow id=d12324e1974 href="http://dx.doi.org/10.1016/S1470-2045(10)70017-6">Publisher Full Text </a> | <a target=xrefwindow id=d12324e1978 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5242182">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d12324e1988 class=n-a></a>Hutcheson KA, Yuk M, Hubbard R, <i> et al.</i>: Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. <i>Head Neck.</i> 2017; <b>39</b>(8): 151623. <a target=xrefwindow id=d12324e1999 href="http://www.ncbi.nlm.nih.gov/pubmed/28452175">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2002 href="http://dx.doi.org/10.1002/hed.24789">Publisher Full Text </a> | <a target=xrefwindow id=d12324e2006 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5511776">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727857911"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e2015 class=n-a></a>Strojan P, Hutcheson KA, Eisbruch A, <i> et al.</i>: Treatment of late sequelae after radiotherapy for head and neck cancer. <i>Cancer Treat Rev.</i> 2017; <b>59</b>: 7992. <a target=xrefwindow id=d12324e2026 href="http://www.ncbi.nlm.nih.gov/pubmed/28759822">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2029 href="http://dx.doi.org/10.1016/j.ctrv.2017.07.003">Publisher Full Text </a> | <a target=xrefwindow id=d12324e2033 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5902026">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727857911">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d12324e2046 class=n-a></a>Yeh DH, Tam S, Fung K, <i> et al.</i>: Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature. <i>Eur J Surg Oncol.</i> 2015; <b>41</b>(12): 160314. <a target=xrefwindow id=d12324e2057 href="http://www.ncbi.nlm.nih.gov/pubmed/26461255">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2060 href="http://dx.doi.org/10.1016/j.ejso.2015.09.007">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725418086"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e2069 class=n-a></a>Lrincz BB, Jowett N, Knecht R: Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective. <i>Head Neck.</i> 2016; <b>38 Suppl 1</b>: E21906. <a target=xrefwindow id=d12324e2077 href="http://www.ncbi.nlm.nih.gov/pubmed/25833809">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2080 href="http://dx.doi.org/10.1002/hed.24059">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725418086">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d12324e2093 class=n-a></a>Haughey BH, Hinni ML, Salassa JR, <i> et al.</i>: Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. <i>Head Neck.</i> 2011; <b>33</b>(12): 168394. <a target=xrefwindow id=d12324e2104 href="http://www.ncbi.nlm.nih.gov/pubmed/21284056">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2107 href="http://dx.doi.org/10.1002/hed.21669">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718071560"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e2116 class=n-a></a>Kofler B, Laban S, Busch CJ, <i> et al.</i>: New treatment strategies for HPV-positive head and neck cancer. <i>Eur Arch Otorhinolaryngol.</i> 2014; <b>271</b>(7): 18617. <a target=xrefwindow id=d12324e2127 href="http://www.ncbi.nlm.nih.gov/pubmed/23934317">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2130 href="http://dx.doi.org/10.1007/s00405-013-2603-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718071560">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d12324e2144 class=n-a></a>Kershaw MH, Westwood JA, Slaney CY, <i> et al.</i>: Clinical application of genetically modified T cells in cancer therapy. <i>Clin Transl Immunology.</i> 2014; <b>3</b>(5): e16. <a target=xrefwindow id=d12324e2155 href="http://www.ncbi.nlm.nih.gov/pubmed/25505964">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2158 href="http://dx.doi.org/10.1038/cti.2014.7">Publisher Full Text </a> | <a target=xrefwindow id=d12324e2162 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4232070">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d12324e2171 class=n-a></a>Robinson M, Schache A, Sloan P, <i> et al.</i>: HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. <i>Head Neck Pathol.</i> 2012; <b>6 Suppl 1</b>: S8390. <a target=xrefwindow id=d12324e2182 href="http://www.ncbi.nlm.nih.gov/pubmed/22782227">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2185 href="http://dx.doi.org/10.1007/s12105-012-0370-7">Publisher Full Text </a> | <a target=xrefwindow id=d12324e2189 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3394162">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d12324e2198 class=n-a></a>Smeets SJ, Hesselink AT, Speel EJ, <i> et al.</i>: A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. <i>Int J Cancer.</i> 2007; <b>121</b>(11): 246572. <a target=xrefwindow id=d12324e2209 href="http://www.ncbi.nlm.nih.gov/pubmed/17680565">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2212 href="http://dx.doi.org/10.1002/ijc.22980">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d12324e2221 class=n-a></a>Singhi AD, Westra WH: Comparison of human papillomavirus <i>in situ</i> hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. <i>Cancer.</i> 2010; <b>116</b>(9): 216673. <a target=xrefwindow id=d12324e2232 href="http://www.ncbi.nlm.nih.gov/pubmed/20186832">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2235 href="http://dx.doi.org/10.1002/cncr.25033">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732865263"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e2244 class=n-a></a>Rosenthal M, Huang B, Katabi N, <i> et al.</i>: Detection of HPV related oropharyngeal cancer in oral rinse specimens. <i>Oncotarget.</i> 2017; <b>8</b>(65): 109393401. <a target=xrefwindow id=d12324e2255 href="http://www.ncbi.nlm.nih.gov/pubmed/29312616">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2258 href="http://dx.doi.org/10.18632/oncotarget.22682">Publisher Full Text </a> | <a target=xrefwindow id=d12324e2262 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5752529">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732865263">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728768609"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e2275 class=n-a></a>Qureishi A, Ali M, Fraser L, <i> et al.</i>: Saliva testing for human papilloma virus in oropharyngeal squamous cell carcinoma: A diagnostic accuracy study. <i>Clin Otolaryngol.</i> 2018; <b>43</b>(1): 1517. <a target=xrefwindow id=d12324e2286 href="http://www.ncbi.nlm.nih.gov/pubmed/28620984">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2289 href="http://dx.doi.org/10.1111/coa.12917">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728768609">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727246319"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12324e2303 class=n-a></a>Lydiatt WM, Patel SG, O'Sullivan B, <i> et al.</i>: Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. <i>CA Cancer J Clin.</i> 2017; <b>67</b>(2): 12237. <a target=xrefwindow id=d12324e2314 href="http://www.ncbi.nlm.nih.gov/pubmed/28128848">PubMed Abstract </a> | <a target=xrefwindow id=d12324e2317 href="http://dx.doi.org/10.3322/caac.21389">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727246319">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 30 Aug 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1362.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1362.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, USA<br/> <sup>2</sup> Department of Otolaryngology Head and Neck Surgery, NHS Lothian, Edinburgh, UK<br/> <p> <div class=margin-bottom> Ashley Hay <br/> <span>Roles: </span> Conceptualization, Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Iain J. Nixon <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1362/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 30 Aug 2018, 7:1362 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14416.1">https://doi.org/10.12688/f1000research.14416.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Hay A and Nixon IJ. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15692 data-id=14416 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14416.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1362/v1/pdf?article_uuid=ffd58d39-9c02-490b-bde7-fa157920a73d" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14416.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Hay A and Nixon IJ. Recent advances in the understanding and management of oropharyngeal cancer [version 1; peer review: 3 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1362 (<a href="https://doi.org/10.12688/f1000research.14416.1" target=_blank>https://doi.org/10.12688/f1000research.14416.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14416 id=mobile-track-article-signin-14416 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14416?target=/articles/7-1362.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15692 /> <input name=articleId type=hidden value=14416 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Terence M. Jones</strong>, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> Prof Jones is Joint Chief Investigator for the clinical trial PATHOS and lead author on several of the cited articles. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Christian von Buchwald</strong>, Department of Otorhinolaryngology, University of Copenhagen, Denmark </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Martin Zamani</strong>, Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Denmark </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Peter Klu&szlig;mann</strong>, Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 30 Aug 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1362.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1362.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=38219-37726></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=38220-37459></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=38221-37727></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1362/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>30 Aug 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Terence M. Jones</strong>, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> Prof Jones is Joint Chief Investigator for the clinical trial PATHOS and lead author on several of the cited articles. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Christian von Buchwald</strong>, Department of Otorhinolaryngology, University of Copenhagen, Denmark </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Martin Zamani</strong>, Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Denmark </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Peter Klu&szlig;mann</strong>, Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1362.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1362/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the understanding and...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1362/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1362/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1362/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Hay A and Nixon IJ');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1362/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1362",
            templates : {
                twitter : "Recent advances in the understanding and management of oropharyngeal.... Hay A and Nixon IJ, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1362/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the understanding and management of oropharyngeal cancer", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the understanding and management of oropharyngeal cancer", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14416/15692")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15692");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "37459": 0,
                           "37726": 0,
                           "37727": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "b4a9d19c-9269-432c-adae-76705849b9cf";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1362.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1362.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1362.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1362.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1362.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>